Condition: Circulating Tumor Cell · Nasopharyngeal Carcinoma · Distant Metastases.Clinical · Sponsor: Sun Yat-sen University
The prospective observational clinical study will recruit 50 metastatic nasopharyngeal carcinoma (mNPC) patients, detecting patient's chemosensitivity with the circulating tumor cells (CTCs) from peripheral blood and prdicting patient's treatment efficacy with CTCs dynamic change.
This description comes directly from the study's public registry record.
Jingjing Miao, M.D · 86-13631355201 · miaojingjing90@163.com
Always discuss trial participation with your own doctor first.
| Cancer Center, Sun Yat-sen University | Guangzhou, Guangdong, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04544969